Form 8-K - Current report:
SEC Accession No. 0001104659-26-093042
Filing Date
2026-08-10
Accepted
2026-08-10 07:50:04
Documents
17
Period of Report
2026-08-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2622673d1_8k.htm   iXBRL 8-K 33714
2 EXHIBIT 1.1 tm2622673d1_ex1-1.htm EX-1.1 250997
3 EXHIBIT 4.1 tm2622673d1_ex4-1.htm EX-4.1 67501
4 EXHIBIT 5.1 tm2622673d1_ex5-1.htm EX-5.1 9123
5 EXHIBIT 99.1 tm2622673d1_ex99-1.htm EX-99.1 9901
9 GRAPHIC tm2622673d1_ex5-1img001.jpg GRAPHIC 3122
10 GRAPHIC tm2622673d1_ex5-1img002.jpg GRAPHIC 846
  Complete submission text file 0001104659-26-093042.txt   633115

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA repl-20260809.xsd EX-101.SCH 3017
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20260809_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20260809_pre.xml EX-101.PRE 22360
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2622673d1_8k_htm.xml XML 3211
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 261256257
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)